Other languages Aspira Women's Health Inc.

Equities

AWH

US04537Y2081

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-23 pm EDT			5-day change	1st Jan Change
3.39 ^USD	-3.14%		-1.74%	-16.91%

Apr. 01	Cantor Fitzgerald Trims Price Target on Aspira Women's Health to $3.30 From $4, Maintains Neutral Rating	MT
Mar. 28	Transcript : Aspira Women's Health Inc., Q4 2023 Earnings Call, Mar 28, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aspira Women's Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
Aspira Women's Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28
Aspira Women's Health Inc. Announces Executive Changes	Mar. 18
Aspira Women's Health Inc. Announces OvaSuite(SM) Distribution Agreement in the Philippines	Feb. 06
Aspira Women's Health Inc. Announces Resignation of Veronica G.H. Jordan from the Board of Directors	Dec. 27
Aspira Women's Health Provides Development Update on its Portfolio of Noninvasive Tests for Endometriosis	Dec. 06
Aspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services	Nov. 27
Aspira Women's Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Aspira Women's Health Sees Poster on its MiRNA-Based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research	23-10-25
Aspira Women's Health Establishes A New Clinical Advisory Board	23-10-23
Sector Update: Health Care Stocks Mixed Late Afternoon	23-09-13
Sector Update: Health Care Stocks Mixed in Afternoon Trading	23-09-13
Top Midday Gainers	23-09-13
Aspira Women's Health Regains Compliance With Nasdaq Listing Rule	23-09-13
Aspira Women?s Health Announces Executive Changes	23-09-11
Aspira Women's Health Signs Serum Sample Procurement Agreement With University of Oxford	23-08-31
Aspira Women's Health Inc. Signs Exclusive Sample Procurement Agreement with the University of Oxford	23-08-31
Aspira Women?s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations	23-08-28
Aspira Women's Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Aspira Women?S Health Inc. Announces Resignation of Ryan Phan as Chief Scientific and Operating Officer, Effective September 15, 2023	23-08-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aspira Women's Health Inc.

Equities

AWH

US04537Y2081

Other languages

Filters